drugset / Trial / NCT05327309

Role of Propranolol as Compared to Bleomycin in Management of Hemangioma

NCT05327309

RandomizedParallel-groupDouble-blindTreatment

Summary

Infantile hemangiomas are widespread vascular tumours having incidence of 10% and most of them involute spontaneously. However, they are known to be located in proximity of vital organs and can have poor cosmetic and functional sequel if left untreated. A wide range of treatment options are available from expectant therapy to radical surgical excision. Propanolol has also been shown to be effective in treating infantile cutaneous hemangiomas. Similarly, anti-metabolite drugs as bleomycin has also shown promising results. Efficacy in terms of reduction in size of both treatments has been scarcely studied especially in Pakistan. OBJECTIVE: To assess the efficacy of oral propranolol and intraleisonal bleomycin in the treatment of infantile cutaneous hemangioma in terms of size regression

Timeline

Start
2015-05-08
Primary completion
2017-05-09
Completion
2018-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Bleomycin Unknown 0.5 mg/kg Other
Subject Propranolol Small molecule 2 mg/kg Oral

Indications